By Alan Johnson and Luke Maunder, Bristows There is a lot of talk about the consequences of an ineffective opt-out, but concentrating on this issue perhaps ignores a more basic one: can anyone even challenge an opt-out? For those who wish to delve into the depths of legal analysis, a treatise on the issue may…

The 30-day period to initiate mandatory arbitration proceedings against apllicants of authorization to introduce generic medicines in the market is an expiration or final term. A full summary of this case has been published on Kluwer IP Law

The Court of Intellectual Property has exclusive jurisdiction to revoke patents. The mandatory arbitration court established by Law 62/2011 cannot declare the nullity of a pharmaceutical patent even if the issue is raised merely as a defence and with effects limited to the parties to the proceedings. A full summary of this case has been…

The Patent Trial and Appeal Board did not err in instituting Covered Business Method (“CBM”) review and finding several claims of a financing method patent owned by Credit Acceptance Corporation (“CAC”) to be directed to a patent-ineligible abstract idea, the U.S. Court of Appeals for the Federal Circuit has ruled. The Board correctly rejected CAC’s…

Another significant delay – or even more substantial – trouble seems to be ahead of the Unitary Patent system, due to today’s decision of the German Constitutional Court (Bundesverfassungsgericht) in Karlsruhe. The Bundesverfassungsgericht has requested the German President not to sign the bills already approved by Bundestag and Bundesrat on the ratification of the Unitary…

Although the title of this blog will sound trite to many friends accustomed to arguing patent cases before the European Patent Office, it does not sound so trite when read against the background of Spanish case law.  For years it was relatively rare for the Spanish Supreme Court to accept appeals in patent matters, which…

The previously announced target date for the entry into operation of the Unified Patent Court, envisaged for December 2017, cannot be maintained. This has been reported by the UPC Preparatory Committee. Today, the Committee announced that the timetable which was published last March, was ‘relying on the timely finalisation of national procedures concerning the ratification…

ECC’s patent strategy not Swiss courts’ cup of tea Ethical Coffee Company (ECC) and different entities of the Nestlé group of companies have been involved in many legal disputes in various jurisdictions. The parties’ positions are normally as follows: ECC seeks access to the Nespresso coffee capsule machines for its biodegradable coffee capsules and Nestlé…

Second medical use cases have been making their way through patent courts around the world. In the Novartis / Sun litigation the Hague Court of Appeal (PI decision) and District Court (interlocutory merits decision) already provided their thoughts on indirect infringement in 2015. The Court of Appeal concluded that Sun did indirectly infringe Novartis’ patent,…

On March 22, 2017, the Beijing IP Court (the “trial court”) issued a decision on a high-profile case Iwncomm v. Sony concerning infringement of a standard essential patent (SEP). This case has drawn extensive attention in China’s IP community because it is the first SEP-based injunction granted by a Chinese court, and it involves quite…